CClinicalTrials.gg
RecruitingNCT06444685Updated Jun 5, 2024

Effects of Table Tennis for People With Parkinson's Disease

An interventional study of Exercise and cognitive training interventino in Parkinson Disease, sponsored by Universitat de Lleida. Recruiting at 1 site in Spain. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-06-05.

Sponsored by Universitat de Lleida · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Oct 2023, registered Mar 2024).
  • Started Oct 2023; still recruiting 3 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games).

Read the detailed description

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games). Interventions in both groups will take place twice a week for 6 weeks (12 sessions in total). The main variables to be assessed will be motor and cognitive. As secondary variables, clinical and daily life aspects will be assessed. As results, it is expected that the experimental group will obtain improvements in motor variables compared to the control group after receiving the interventions. However, improvements in cognitive variables and secondary variables are expected to be similar in both groups.

02

Conditions studied

  • Parkinson Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of Parkinson's Disease based on the UK PD Society Brain Bank Criteria
  • Stage I to III on the Hoehn and Yahr scale
  • Ability to walk for 10 minutes unassisted

Exclusion criteria

Exclusion Criteria:

  • Score of under 23 on the Mini-Mental State Examination
  • Severe Visual or Auditory deficits
  • Cardiovascular conditions that impede physical activity
  • Brain surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Table Tennis

    Participants will follow supervised Table Tennis sessions lasting 60 minutes during 6 weeks, for a total of 12 sessions.

    Other: Exercise and cognitive training interventino

  • Experimental
    Tabletop Games

    Participants will follow supervised Tabletop Game sessions lasting 60 minutes during 6 weeks, for a total of 12 sessions.

    Other: Exercise and cognitive training interventino

Interventions

  • OtherExercise and cognitive training interventino

    Exercise and cognitive training based on Table tennis and Tabletop games.

06

What researchers measure

Primary outcomes

  1. Amplitude of Center of Pressure under simple conditions

    Assessment of amplitude of Center of Pressure (in mm) during balance testing using OPAL Sensors (APDM, Oregon, USA).

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  2. Amplitude of Center of Pressure under Dual Task conditions (Motor)

    Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Motor, by holding a glass of water on a tray) using OPAL Sensors (APDM, Oregon, USA).

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  3. Amplitude of Center of Pressure under Dual Task conditions (Arithmetic)

    Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Arithmetic, by concurrently substracting 7 from a random number) using OPAL Sensors (APDM, Oregon, USA).

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  4. Amplitude of Center of Pressure under Dual Task conditions (Verbal)

    Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Verbal, by naming words starting by a random letter) using OPAL Sensors (APDM, Oregon, USA).

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  5. Trail-Making Test

    Assessment of Trail-Making Test parts A and B

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Secondary outcomes

  1. United Parkinson's Disease Rating Scale - Part III

    Assessment of Motor symptoms of Parkinson's Disease with a predetermined assessment

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  2. Montreal Cognitive Assessment

    Assessment of cognitive status to detect Mild Cognitive Impairment with a preset questionnaire.

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  3. Parkinson's Disease Questionnaire - 8

    Assessment of Quality of Life for people with Parkinson's Disease through a self-administered questionnaire

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  4. Timed Up and Go test

    Assessment of gait mobility and fall risk by getting up from a chair, walking 3 meters, turning back and sitting again.

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

  5. Falls Efficacy Scale International

    Assessment of perceived fall risk with a predetermined questionnaire.

    Time frame: Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res. 1990;85:119-46. PubMed 2094891 ↗
  • Shahed J, Jankovic J. Motor symptoms in Parkinson's disease. Handb Clin Neurol. 2007;83:329-42. doi: 10.1016/S0072-9752(07)83013-2. No abstract available. PubMed 18808920 ↗
  • Inoue K, Fujioka S, Nagaki K, Suenaga M, Kimura K, Yonekura Y, Yamaguchi Y, Kitano K, Imamura R, Uehara Y, Kikuchi H, Matsunaga Y, Tsuboi Y. Table tennis for patients with Parkinson's disease: A single-center, prospective pilot study. Clin Park Relat Disord. 2020 Dec 30;4:100086. doi: 10.1016/j.prdoa.2020.100086. eCollection 2021. PubMed 34316664 ↗
  • Olsson K, Franzen E, Johansson A. A Pilot Study of the Feasibility and Effects of Table Tennis Training in Parkinson Disease. Arch Rehabil Res Clin Transl. 2020 Jun 2;2(3):100064. doi: 10.1016/j.arrct.2020.100064. eCollection 2020 Sep. PubMed 33543090 ↗
  • Estrada-Plana V, Montanera R, Ibarz-Estruga A, March-Llanes J, Vita-Barrull N, Guzman N, Ros-Morente A, Ayesa Arriola R, Moya-Higueras J. Cognitive training with modern board and card games in healthy older adults: two randomized controlled trials. Int J Geriatr Psychiatry. 2021 Jun;36(6):839-850. doi: 10.1002/gps.5484. Epub 2021 Jan 8. PubMed 33275804 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06444685
Lead sponsor
Universitat de Lleida
Collaborators
Club Tennis Taula Borges Blanques, Asociació de Parkinson de les Terres de Lleida
Responsible party
Helena Fernández-Lago (Lecturer, Universitat de Lleida) — Principal investigator
First posted
Jun 5, 2024
Start date
Oct 1, 2023
Primary completion
Jun 30, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Jun 5, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion